TARS - Tarsus Pharmaceuticals GAAP EPS of -$0.67 misses by $0.10 revenue of $57.03M beats by $7.96M March, 14 2022 05:52 PM Tarsus Pharmaceuticals Inc. Tarsus Pharmaceuticals press release (NASDAQ:TARS): FY GAAP EPS of -$0.67 misses by $0.10. Revenue of $57.03M beats by $7.96M. For further details see: Tarsus Pharmaceuticals GAAP EPS of -$0.67 misses by $0.10, revenue of $57.03M beats by $7.96M